|
|
Value of lactic acid parameters in predicting emergency death and rebleeding within 30 days in patients with nonvariceal upper gastrointestinal bleeding |
LIANG Junrong1, ZHOU Yongqiang1, HU Kang1, LI Chunyan1, HE Xiaoyi2, LIU Yanjun2 |
1. Department of Gastroenterology, 2. Department of Endocrinology,the 987th Hospital of PLA Joint logistics Support Force,Baoji 721004,China |
|
|
Abstract Objective To investigate the value of lactic acid parameters in predicting emergency death and rebleeding within 30 days in patients with nonvariceal upper gastrointestinal bleeding (NVUGIB). Methods Clinical data of 924 adult NVUGIB patients admitted to the the 987th Hospital of PLA Joint logistics Support Force from May 2017 to October 2023 were retrospectively analyzed. The level of intravenous lactate was determined, the initial, highest and average lactate levels were recorded within 24 h after admission, and lactate clearance rate(LCR) was calculated. Study outcomes included death in the emergency department and rebleeding within 30 days after admission. Results The levels of initial lactic acid, maximum lactic acid and average lactic acid in emergency patients were significantly higher than those in survivors(P<0.05), and the LCR was significantly lower than that in survival group, with statistical significance (P<0.05). In addition, the LCR of patients with rebleeding within 30 days was significantly lower than that of those without bleeding (P<0.05). Multivariate logistic regression analysis showed that initial lactic acid, maximum lactic acid, average lactic acid, LCR and AIMS65 scores were independent risk factors for emergency death with NVUGIB (P<0.05). LCR and AIMS65 scores were independent influencing factors for 30 days of rebleeding in NVUGIB patients (P<0.05). The area under ROC curve (AUC) of initial lactic acid, maximum lactic acid, average lactic acid and LCR in predicting emergency death of NVUGIB were 0.833(95%CI: 0.763-0.903), 0.813(95%CI: 0.736-0.890), 0.809(95%CI: 0.736-0.890) and 0.766(95%CI: 0.684-0.848), respectively. The AUC of LCR in predicting rebleeding within 30 days in patients with NVUGIB reached 0.844 (95%CI: 0.789-0.899). When the above lactate parameters were combined with AIMS65 score, the prediction ability of the model for the risk of death and rebleeding was improved. Conclusions Elevated lactate levels or decreased LCR are associated with poor prognosis of NVUGIB, and lactate parameters are expected to be an early predictor of NVUGIB emergency death and 30-day rebleeding risk stratification.
|
Received: 10 June 2024
|
|
|
|
|
[1] |
Banigan M, Kranenburg L, Vise J. Upper gastrointestinal bleeding: evaluation and diagnosis[J]. Gastroenterol Nurs, 2023, 46(5): 348-358.
|
[2] |
Gralnek I M, Stanley A J, Morris A, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage(NVUGIH): european society of gastrointestinal endoscopy(ESGE) guideline-update 2021[J].Endoscopy, 2021, 53(3): 300-332.
|
[3] |
Aktas G, Ustaoglu M, Bakir T, et al. Analysis of the patients with nonvariceal upper gastrointestinal bleeding and comparison of Rockall and Glasgow-Blatchford scores[J].Indian J Gastroenterol, 2022, 41(6): 576-582.
|
[4] |
Kim M S, Moon H S, Kwon I S, et al. Validation of a new risk score system for non-variceal upper gastrointestinal bleeding[J]. BMC gastroenterol, 2020, 20(1): 193-202.
|
[5] |
杨 威, 钟德金, 王力涛, 等. 血清PGE-2和血乳酸水平与急性上消化道出血病情严重程度及预后的相关性分析[J]. 中国现代医学杂志, 2022, 32(19): 25-31.
|
[6] |
李 会, 苏海滨, 王永刚, 等. 乳酸对慢加急性肝衰竭合并感染患者预后的临床预测价值分析[J]. 中华肝脏病杂志, 2023, 31(3): 300-306.
|
[7] |
杨 烁, 刘 坤, 杨 兰, 等. 乳酸水平对HBV相关慢加急性肝衰竭患者短期预后的预测价值[J]. 临床肝胆病杂志, 2022, 38(7): 1482-1488.
|
[8] |
王晓红, 斯日古楞, 贾志新, 等. 万古霉素药物浓度监测在治疗严重脓毒症中的临床应用[J]. 武警医学, 2024, 35(6): 516-519.
|
[9] |
杨惠安, 俞晓玲, 黄水文, 等. 国家早期预警评分2联合血乳酸预测重症社区获得性肺炎患者短期预后的价值[J]. 中国感染控制杂志, 2023, 22(2): 200-207.
|
[10] |
Martínez-Solano J, Sousa-Casasnovas I, Bellón-Cano J M, et al. Lactate levels as a prognostic predict in cardiogenic shock under venoarterial extracorporeal membrane oxygenation support[J].Rev Esp Cardiol(Engl Ed), 2022, 75(7): 595-603.
|
[11] |
Strzałka M, Winiarski M, Dembinski M, et al. Predictive role of admission venous lactate level in patients with upper gastrointestinal bleeding: a prospective observational study[J].J Clin Med, 2022, 11(2): 335-344.
|
[12] |
Kim K, Lee D H, Lee D H, et al. Early lactate clearance for predicting outcomes in patients with gastrointestinal bleeding[J].Ir J Med Sci, 2023, 192(4): 1923-1929.
|
[13] |
Allo G, Gillessen J, Gülcicegi D, et al. Comparison of lactate clearance with established risk assessment tools in predicting outcomes in acute upper gastrointestinal bleeding[J].J Clin Med, 2023, 12(7): 2716-2726.
|
[14] |
Kim M S, Choi J, Shin W C. AIMS65 scoring system is comparable to glasgow-blatchford score or rockall score for prediction of clinical outcomes for non-variceal upper gastrointestinal bleeding[J].BMC Gastroenterol, 2019, 19(1): 136-142.
|
[15] |
Asotibe J C, Shaka H, Akuna E, et al. Outcomes of non-variceal upper gastrointestinal bleed stratified by hospital teaching status: insights from the National Inpatient sample[J]. Gastroenterology Res, 2021, 14(5): 268-274.
|
[16] |
Li X, Yang Y, Zhang B, et al. Lactate metabolism in human health and disease[J]. Signal Transduct Target Ther, 2022, 7(1): 305.
|
[17] |
Wu M, Shi L, Zhang H, et al. Predictive value of arterial blood lactic acid concentration on the risk of all-cause death within 28 days of admission in patients with severe acute pancreatitis[J].Postgrad Med, 2022, 134(2): 210-216.
|
[18] |
Zeng F, Du L, Ling L. Lactate level as a predictor of outcomes in patients with acute upper gastrointestinal bleeding: a systematic review and metaanalysis[J].Exp Ther Med, 2024, 27(3): 113-120.
|
[19] |
Zanza C, Facelli V, Romenskaya T, et al. Lactic acidosis related to pharmacotherapy and human diseases[J]. Pharmaceuticals, 2022, 15(12): 1496.
|
[20] |
Chang A, Ouejiaraphant C, Akarapatima K, et al. Prospective comparison of the AIMS65 score, glasgow-blatchford score, and rockall score for predicting clinical outcomes in patients with variceal and nonvariceal upper gastrointestinal bleeding[J].Clin Endosc, 2021, 54(2): 211-221.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(11): 991-992. |
|
|
|
|